Bradycardia and Hypotension Management Post-Subarachnoid Hemorrhage

Diagnostic Considerations

Blood pressure variability from autonomic dysfunction is associated with worse neurological outcomes and can present as episodic hypotension, according to the American Heart Association 1, 2
Day 14 falls within the peak window for Delayed Cerebral Ischemia (DCI), which can present with hemodynamic instability as the brain's autoregulation fails, as stated by the American Stroke Association 1, 3

Hyponatremia occurs in 10-30% of Subarachnoid Hemorrhage (SAH) patients and is associated with volume contraction, which can contribute to hypotension, as reported by the American Heart Association 4, 5
Volume depletion is documented in 58% of patients who develop DCI and can cause hypotension, according to the American Stroke Association 1
Hypomagnesemia is common after SAH and associated with poor outcomes, though primarily affects vasospasm risk rather than direct cardiovascular effects, as stated by the American Heart Association 6

Assess volume status using a combination of central venous pressure, cardiac output monitoring, and fluid balance rather than CVP alone, as recommended by the American Stroke Association 1
Check electrolytes, specifically sodium and magnesium levels, as suggested by the American Heart Association 4, 6
Evaluate for DCI by performing a neurological examination and considering transcranial Doppler or perfusion imaging, as stated by the American Stroke Association 1, 3

Do not discontinue nimodipine entirely without careful consideration, as it remains the only proven therapy for preventing DCI and should be continued even with mild hypotension that can be managed with vasopressors, according to the American Stroke Association 1
Avoid aggressive fluid resuscitation for hypotension, as hypervolemia is associated with worse outcomes; maintain euvolemia instead, as recommended by the American Stroke Association 1
Avoid excessive blood pressure variability, as rapid fluctuations are associated with increased rebleeding risk and worse outcomes, as stated by the American Heart Association 1, 2